Laddar...
Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
BACKGROUND: Sodium‐glucose cotransporter (SGLT) 2 inhibitors were recently approved as glucose‐lowering interventions in people with type 2 diabetes mellitus (T2DM). Potential beneficial or harmful effects of SGLT 2 inhibitors in people at risk for the development of T2DM are unknown. OBJECTIVES: To...
Sparad:
| I publikationen: | Cochrane Database Syst Rev |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley & Sons, Ltd
2016
|
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486006/ https://ncbi.nlm.nih.gov/pubmed/27101360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012106.pub2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|